iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
74.36
+0.62 (0.84%)
Nov 21, 2024, 11:24 AM EST - Market open
iRhythm Technologies Employees
iRhythm Technologies had 2,000 employees as of December 31, 2023. The number of employees increased by 207 or 11.54% compared to the previous year.
Employees
2,000
Change (1Y)
207
Growth (1Y)
11.54%
Revenue / Employee
$280,013
Profits / Employee
-$75,328
Market Cap
2.33B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ardent Health Partners | 23,000 |
| Zai Lab | 2,175 |
| Twist Bioscience | 919 |
| LeMaitre Vascular | 630 |
| Arrowhead Pharmaceuticals | 525 |
| Scholar Rock Holding | 150 |
| Geron | 141 |
| Protagonist Therapeutics | 112 |
IRTC News
- 19 hours ago - iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference - GlobeNewsWire
- 3 days ago - iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring - GlobeNewsWire
- 15 days ago - iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - GlobeNewsWire
- 21 days ago - iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device - GlobeNewsWire
- 21 days ago - iRhythm Technologies Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 24 days ago - Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy - GlobeNewsWire
- 4 weeks ago - With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says - Benzinga